Výsledky vyhledávání - "Group, T.C.M."

The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK

Autor: Meiring, J.E., Gibani, M., Basnyat, B., Bentsi-Enchill, A.D., Clemens, J., Darton, T.C., Date, K., Dougan, G., Garrett, D., Gessner, B.D., Gordon, M.A., Heyderman, R.S., Hombach, J., Kotloff, K.L., Levine, M.M., Luby, S.P., Mohan, V.K., Marfin, A.A., Mulholland, K., Neuzil, K., Pitzer, V.E., Pollard, A.J., Qadri, F., Salisbury, D., Zaidi, A., Group, T.C.M.

Publikováno v: VACCINE

Typhoid fever is estimated to cause between 11.9–26.9 million infections globally each year with 129,000–216,510 deaths. Access to improved water sources have reduced disease incidence in parts of the world but the use of efficacious vaccines is

Vyhledávací nástroje:

Upřesnit hledání